17 07, 2024

ASML’s Q2 Earnings and Sales Beat the Estimate, But the Stock is Down 10%: Should You Sell?

By |2024-07-17T17:21:25+00:00July 17th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , , , , , |

ASML (ASML) reported second-quarter earnings that surpassed Wall Street’s expectations on both the top and bottom lines and yet, the market responded by sending shares 10% lower. The Dutch semiconductor manufacturer saw a surge in demand for the quarter, beating its original forecast and culminating in the following results: Sales: $6.79 billion vs $6.53 [...]

8 07, 2024

Morgan Stanley Upgrades TSM Ahead of Earnings: 3 Reasons to Buy This Stock Today

By |2024-07-08T16:46:58+00:00July 8th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , , |

Shares of Taiwan Semiconductor Manufacturing Company (TSM) got a 3% boost Monday morning after analysts with Morgan Stanley were the latest to upgrade the stock.  The company is set to release its earnings on July 18th, and more and more experts are paying attention to the stock as the date approaches - you should [...]

18 07, 2023

AudioCodes is Down 55% This Year, and it May Get Worse: Time to Sell?

By |2023-07-19T17:46:58+00:00July 18th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , |

Recursion Pharmaceuticals (RXRX) just got an endorsement from one of Wall Street’s hottest stocks at the moment, and as such, has earned the attention of analysts, retail investors, and professionals alike. After securing a $50 million investment from Nvidia (NVDA), the RXRX shot up more than 76%. The two companies are more alike than [...]

Go to Top